| 摘要: |
| 目的:探讨儿科美罗培南使用评价体系,为儿科美罗培南合理应用提供参考。方法:构建儿科美罗培南药物利用评价
(DUE)标准,采用加权逼近理想解排序(TOPSIS)法对2020 年10 月至2021 年3 月我院儿科使用美罗培南的患儿临床资料进行
评价。结果:共纳入130 例合格病例,根据其与最佳解的相对接近程度Ci 值进行划分,Ci ≥0. 8 的合理病例38 例(29. 23%),
0. 6≤Ci <0. 8 的基本合理病例60 例(46. 15%),Ci <0. 6 的不合理病例32 例(24. 62%)。结论:采用加权TOPSIS 法评估儿科美
罗培南的合理应用是切实可行的,我院美罗培南的应用仍存在问题,应加强管理,促进美罗培南在儿科患者中的合理应用。 |
| 关键词: 加权TOPSIS 法 美罗培南 儿童 |
| DOI：10.13407/j.cnki.jpp.1672-108X.2023.03.004 |
|
| 基金项目: |
|
| Drug Use Evaluation of Meropenem Used in Pediatrics Based on Weighted TOPSIS Method |
| Yin Cunlin, Zhang Yaming, Huang Lei |
| (Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School,Jiangsu Yancheng 224005, China) |
| Abstract: |
| Objective: To discuss the evaluation system of pediatric meropenem to provide reference for its rational use in pediatrics.
Methods: The standards of pediatric meropenem drug use evaluation (DUE) were constructed, and the weighted TOPSIS method was
used to evaluate pediatric patients who used meropenem in the pediatrics department of our hospital from October 2020 to March 2021.
Results: A total of 130 eligible cases were collected. According to their relative closeness to the optimal solution, 38 cases (29. 23%)
were reasonable with Ci ≥ 0. 8, 60 cases (46. 15%) were basically reasonable with 0. 6 ≤ Ci < 0. 8, and 32 cases (24. 62%) were
unreasonable with Ci < 0. 6. Conclusion: It is reasonable and feasible to use weighted TOPSIS method to evaluate meropenem in
pediatrics. There are still some problems in the use of meropenem in our hospital, so we should strengthen the management and urge it
to the optimal solution |
| Key words: weighted TOPSIS method meropenem children |
